Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine

Conditions: Vaccination Reaction Interventions: Biological: TETRALITE Sponsors: LiteVax BV; University Hospital, Ghent; HarmonyCR, Melle, Belgium Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials